The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary results of V-FAST, a phase 1b master trial to investigate CPX-351 combined with targeted agents in newly diagnosed AML.
 
Vinod Pullarkat
Honoraria - Amgen; Dova Pharmaceuticals; Novartis
Consulting or Advisory Role - Amgen; Dova Pharmaceuticals; Novartis
Speakers' Bureau - AbbVie; Amgen; Genentech; Jazz Pharmaceuticals; Novartis; Pfizer; SERVIER
 
Mark J. Levis
Consulting or Advisory Role - Abbvie/Genentech; Agios; Amgen; Astellas Pharma; Bristol-Myers Squibb; Daiichi Sankyo; Fujifilm; GlaxoSmithKline; GlaxoSmithKline; Menarini
Research Funding - Astellas Pharma (Inst); Fujifilm (Inst)
Expert Testimony - Pfizer
Travel, Accommodations, Expenses - Astellas Pharma
 
Gabriel N. Mannis
Consulting or Advisory Role - Abbvie; Agios; Astellas Pharma; Bristol-Myers Squibb; Genentech; Pfizer; Stemline Therapeutics
Research Funding - Gilead/Forty Seven; GlycoMimetics; Jazz Pharmaceuticals
 
Stephen Anthony Strickland
Consulting or Advisory Role - AbbVie; Archer; Genentech; Incyte; Kura Oncology; Novartis; Pfizer; Syros Pharmaceuticals
Research Funding - Sunesis Pharmaceuticals
 
Tara L. Lin
Research Funding - Abbvie (Inst); Aptevo Therapeutics (Inst); Astellas Pharma (Inst); Bio-Path Holdings, Inc (Inst); Celator (Inst); Celgene (Inst); Celyad (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); incyte (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Prescient Therapeutics (Inst); Seagen (Inst); Tolero Pharmaceuticals (Inst); Trovagene (Inst)
 
Stefan Faderl
Employment - Jazz Pharmaceuticals
Stock and Other Ownership Interests - Jazz Pharmaceuticals
 
Divya Chakravarthy
Employment - Jazz Pharmaceuticals
Stock and Other Ownership Interests - Jazz Pharmaceuticals
 
Vijayalakshmi Chandrasekaran
Employment - Jazz Pharmaceuticals
Stock and Other Ownership Interests - Jazz Pharmaceuticals
 
Ronald Cheung
Employment - Jazz Pharmaceuticals
Stock and Other Ownership Interests - Jazz Pharmaceuticals
 
Harry Paul Erba
Consulting or Advisory Role - Abbvie/Genentech; Agios; Amgen; Astellas Pharma; Celgene; Daiichi Sankyo; Glycomimetics; Immunogen; Incyte; Janssen Oncology; Jazz Pharmaceuticals; Kura Oncology; Macrogenics; Novartis; Pfizer; Takeda; Trillium Therapeutics
Speakers' Bureau - Abbvie/Genentech; Agios; Celgene; Incyte; Jazz Pharmaceuticals; Novartis
Research Funding - Abbvie; Abbvie (Inst); Agios (Inst); ALX Oncology (Inst); Amgen (Inst); Daiichi Sankyo (Inst); FORMA Therapeutics (Inst); Gilead/Forty Seven (Inst); Glycomimetics (Inst); Immunogen (Inst); Jazz Pharmaceuticals (Inst); Macrogenics (Inst); Novartis (Inst); PTC Therapeutics (Inst)
Other Relationship - Celgene; Glycomimetics
(OPTIONAL) Uncompensated Relationships - Daiichi Sankyo